Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Journey Medical Corp (DERM)

Journey Medical Corp (DERM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Journey Medical Corp 9237 E VIA DE VENTURA BLVD. SUITE 105 SCOTTSDALE AZ 85258 USA

www.jmcderm.com Employees: 41 P: 480-434-6670

Sector:

Medical

Description:

Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.

Key Statistics

Overview:

Market Capitalization, $K 154,312
Enterprise Value, $K 155,502
Shares Outstanding, K 33,257
Float, K 28,258
% Float 84.97%
Short Interest, K 2,632
Short Float 7.91%
Days to Cover 30.98
Short Volume Ratio 0.78
% of Insider Shareholders 15.03%
% of Institutional Shareholders 7.25%

Financials:

Annual Sales, $ 61,860 K
Annual Net Income, $ -11,430 K
Last Quarter Sales, $ 16,080 K
Last Quarter Net Income, $ -1,250 K
EBIT, $ -3,910 K
EBITDA, $ 900 K

Growth:

1-Year Return -26.28%
3-Year Return 209.33%
5-Year Return 0.00%
5-Year Revenue Growth 38.92%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 03/25/26
Next Earnings Date 05/13/26
Earnings Per Share ttm -0.47
EPS Growth vs. Prev Qtr 55.56%
EPS Growth vs. Prev Year -150.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

DERM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 23.10
Price/Earnings to Growth N/A
Return-on-Equity % -46.40%
Return-on-Assets % -13.22%
Profit Margin % -18.48%
Debt/Equity 0.79
Price/Sales 2.52
Price/Cash Flow N/A
Price/Book 4.58
Book Value/Share 0.96
Interest Coverage -2.07
60-Month Beta 1.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.